Glutathione-enhancing agents protect against steatohepatitis in a dietary model

Journal of Biochemical and Molecular Toxicology

Volumn 20, Issue 1, 2006, Pages 39-47

  Oz, Helieh S ^a   Im, Hee Jeong ^b   Chen, Theresa S ^c   De Villiers, Willem J S ^a   McClain, Craig J ^c,d  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c University of Louisville School of Medicine   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Glutathione enhancing; PTCA; SAMe; Steatohepatitis

Indexed keywords

2 N PROPYLTHIAZOLIDINE 4 CARBOXYLIC ACID; AMINO ACID; AMINOTRANSFERASE; CHOLINE; COLLAGEN; COLLAGEN ALPHA1; GLUTATHIONE; INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE; METHIONINE; S ADENOSYLMETHIONINE; SUPPRESSOR OF CYTOKINE SIGNALING 1; THIAZOLIDINE DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENTERITIS; FATTY LIVER; FIBROSIS; GENE EXPRESSION; HEMATOCRIT; HEPATITIS; JEJUNOILEAL BYPASS; LIVER NECROSIS; LIVER PROTECTION; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PARENTERAL NUTRITION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CHOLINE; CYTOKINES; DISEASE MODELS, ANIMAL; FATTY LIVER; FOOD, FORMULATED; INFLAMMATION; LIPOTROPIC AGENTS; MALE; METHIONINE; RATS; RATS, SPRAGUE-DAWLEY; S-ADENOSYLMETHIONINE; THIAZOLES; TRANSAMINASES;

ANIMALIA;

EID: 33344471273     PISSN: 10956670     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbt.20109     Document Type: Article

References (33)

1. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clinic Proc 1980;55:434-438.
2. Feher J, Lengyel G. A new approach to drug therapy in non-alcoholic steatohepatitis. J Int Med Res 2003;315: 37-51.
3. Chawla RK, Watson WH, Eastin CE, Lee EY, Schmidt J, McClain CJ. S-adenosylmethionine deficiency and TNF-α in lipopolysaccharide-induced hepatic injury. Am J Physiol 1998;275:G125-G129.
4. Osmundsen H, Bremer J, Pedersen JI. Metabolic aspects of peroxisomal beta-oxidation. Biochim Biophys Acta 1991;1085:141-158.
5. Albano E. Free radical mechanisms in immune reactions associated with alcoholic liver disease. Free Radic Biol Med 2002;32:110-114.
6. Thurman RG, Bradford BU, Iimuro L, Knecht KT, Arteel GE, Yin M, Connor DH, Wall C, Raleigh JA, Frankenberg MV, Adachi Y, Forman DT, Brenner D, Kadiiska M, Mason RP. The role of gut-derived bacterial toxins and free radicals in alcohol-induced liver injury. J Gastroenterol Hepatol 1998;13(Suppl):S39-S50.
7. Pappo I, Bercovier H, Berry EM, Haviv Y, Gallily R, Freund HR. Polymyxin B reduces total parenteral nutrition-associated hepatic steatosis by its antibacterial activity and by blocking deleterious effects of lipopolysaccharide. J Parenter Enter Nutr 1992;16: 529-532.
8. Sorensen P, Edal AL, Madsen EL, Fenger C, Poulsen MR, Petersen OF. Reversible hepatic steatosis in patients treated with interferon alpha-2a and 5-fluorouracil. Cancer 1995;75:2592-2596.
9. Gilbert DL, Colton CA. Reactive oxygen species in biological systems: An interdisciplinary approach. New York: Plenum; 1999.
10. Yermolaieva O, Xu R, Schinstock C, Brot N, Weissbach H, Heinemann SH, Hoshi T. Methionine sulfoxide reductase A protects neuronal cells against brief hypoxia/reoxygenation. Proc Natl Acad Sci USA 2004;101:1159-1164.
11. Lu SC. S-Adenosylmethionine. Int J Biochem Cell Biol 2000;32:391-395.
12. Oz HS, McClain CJ, Nagasaw HT, Ray MB, de Villiers WSJ, Chen TS. Diverse antioxidants protect against acetaminophen hepatotoxicity. J Biochem Mol Toxicol 2004;18:361-368.
13. Oz HS, Chen T, McClain CJ, de Villiers WJS. Antioxidants a novel therapy in a murine model of colitis J Nutr Biochem 2005;16:297-304.
14. Nagasawa HT, Goon DJW, Muldoon WP, Zera RT. 2-Substituted thiazolidine-4(R)-carboxylic acids as pro-drugs of L-cysteine. Protection of mice against acetaminophen hepatotoxicity. J Med Chem 1984;27: 591-596.
15. Chen TS, Richie JP, Nagasawa HT, Lang CA. Glutathione monoethyl ester protects against glutathione deficiencies due to aging and acetaminophen in mice. Mech Age Dev 2000;120:127-139.
16. Sligte te K, Bourass KI, Sels JP, Driessen A, Stockbrugger RW, Koek GH. Non-alcoholic steatohepatitis: Review of a growing medical problem. Eur J Intern Med 2004;15:10-21.
17. Robinson MK, Rounds JD, Hong RW, Jacobs DO, Wilmore DW. Glutathione deficiency increases organ dysfunction after hemorrhagic shock. Surgery 1992;112:140-147, 148-149.
18. Lieber CS. S-Adenosyl-L-methionine and alcoholic liver disease in animal models: Implications for early intervention in human beings. Alcohol 2002;27:173-177.
19. Pessayre D, Fromenty B, Mansouri A. Mitochondrial injury in steatohepatitis. Eur J Gastroenterol Hepatol 2001;16:1095-1105.
20. McClain CJ, Prakash S, Mokshagundam L, Barve S, Song Z, Hill D, Chen T, Deaciuc I. Mechanisms of non-alcoholic steatohepatitis. Alcohol 2004;34:67-79.
21. Mehta K, Van Thiel DH, Shah N, Mobarhan S. Nonalcoholic fatty liver disease: Pathogenesis and the role of antioxidants. Nutr Rev 2002;60:289-293.
22. George J, Pera N, Phung N, Leclercq I, Yun Hou J, Farrell G. Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. J Hepatol 2003;39:756-764.
23. Starkel P, Sempoux C, Leclercq I, Herin M, Deby C, Desager JP, Horsmans Y. Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats. J Hepatol 2003;39: 538-546.
24. Brinckerhoff CE, Matrisian LM. Matrix metalloproteinases: A tail of a frog that became a prince. Nat Rev Mol Cell Biol 2002;3:207-214.
25. Dubois B, Starckx S, Pagenstecher A, Oord J, Arnold B, Opdenakker G. Gelatinase B deficiency protects against endotoxin shock. Eur J Immunol 2002;32:2163-2171.
26. Bond M, Fabunmi RP, Baker AH, Newby AC. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: An absolute requirement for transcription factor NF-kappa B. FEBS Lett 1998;435:29-34.
27. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999;274:21491-21494.
28. Saren P, Welgus HG, Kovanen PT. TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 1996;157:4159-4165.
29. Coussens LM, Werb Z. Matrix metalloproteinases and the development of cancer. Chem Biol 1996;3:895-904.
30. Pugin J, Widmer MC, Kossodo S, Liang CM, Preas HL, Suffredini AF. Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators. Am J Respir Cell Mol Biol 1999;20: 458-464.
31. Yoshida T, Ogata H, Kamio M, Joo A, Shiraishi H, Tokunaga Y, Sata M, Nagai H, Yoshimura A. SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis. J Exp Med 2004;199:1701-1707.
32. Gearing AJ, Beckett P, Christodoulou M, et al. Processing of tumor necrosis factor-alpha precursor by metalloproteinases. Nature 1994;370:555-557.
33. Bullen DV, Darwiche R, Metcalf D, Handman E, Alexander WS. Neutralization of interferon-gamma in neonatal SOCS1-/- mice prevents fatty degeneration of the liver but not subsequent fatal inflammatory disease. Immunology 2001;104:92-98.